Goldline Pharmaceutical IPO
Goldline Pharmaceuticals is one of the leading companies involved in the marketing of pharmaceutical products under the name Goldline. Its products are divided into 5 segments: 1. Goldline Pharma, which includes specialities like Physicians, Orthopedics, ENT, Chest Physicians, General and Speciality Surgery, Gastroenterology, Neurology, and Urology, 2. Goldline Cardinal, which includes specialities like Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians, 3. Goldline Ayushman, which includes Pediatricians, Child Specialists, Neonatologists, and General Practitioners, 4. Goldline InLife, which includes Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians, and 5. Goldline Wellness, which includes cancer therapy.
Price Band
Lot Size
Issue Size
Current GMP
IPO Timeline
Subscription Status
Overall subscription
Financial Information
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹19.85 | ₹19.45 | ₹0.26 | ₹19.39 |
| 2024 | ₹23.57 | ₹21.04 | ₹1.81 | ₹22.93 |
| 2025 | ₹28.06 | ₹24.20 | ₹2.83 | ₹26.28 |
| Dec 2025 | ₹21.41 | ₹18.40 | ₹2.22 | ₹27.40 |
Promoters
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 69,00,000 | 79.70% |
| Promoter Holding Post Issue | 96,00,000 | -% |
Objects of the Issue
- Cumulative Capital Pvt. Ltd.